Stay informed about the advancements in prostate cancer treatment and patient engagement strategies.
Prostate cancer research and treatment advancements continue to evolve, with studies like the Australian phase II TheraP trial showing promising overall survival rates. Understanding the side effects of different treatments is crucial for making informed decisions. With over 400 men diagnosed weekly, survival rates for prostate cancer are high, emphasizing the importance of patient education.
A proactive approach through patient engagement can reduce decisional regret and enhance treatment outcomes. The TETFund NRF Grants providing N34m to YABATECH researchers for precision medicine in prostate cancer is a significant step towards personalized treatment solutions.
However, challenges persist, as seen in the Verzenio flop and its impact on tumor progression. Functional outcomes post-treatment reveal adverse effects in localized prostate cancer cases. Data-driven insights are crucial for evaluating survival rates and treatment impacts on various functions.
Combatting dehumanizing language in medical discourse is vital, as Dr. Regina Barragan-Carrillo highlights the importance of respectful communication in prostate cancer care.
As reported in The Lancet Oncology by Michael S. Hofman, MBBS, and colleagues, the Australian phase II TheraP trial has shown similar overall survival with ...
Understanding the pros and cons of different treatments may help men and their health care teams make more informed treatment decisions. Doctor showing ...
Every week, more than 400 men are diagnosed with prostate cancer. With treatment, survival rates for prostate cancer are high, but understanding the ...
The more informed the patients are, the more likely they are to participate in decision makingโฆPatient engagement in decisions reduces decisional regret and ...
The grant aims to enable researchers to develop an artificial intelligence-based precision medicine solution for prostate cancer treatment that can potentially ...
Verzenio failed to significantly prolong the time before tumor progression or death when added to Johnson & Johnson's Zytiga and the corticosteroid prednisone ...
In an observational cohort study reported in JAMA, Al Awamlh et al identified adverse functional outcomes after localized prostate cancer treatment among ...
It evaluates survival rates, cancer recurrence, secondary treatments, and impacts on urinary, bowel, and sexual function. This data-driven approach aims to ...
In an interview with Targeted Oncology, Regina Barragan-Carrillo, MD, discussed the findings from her analysis of the Language of Respect guidelines adopted ...